Saudi Arabia SFDA registration ME0000003094SFDAA00054
LIAISON Control Rubella IgM
Saudi Arabia·Chemicals·DiaSorin S.p.A.·Annex II List BActiveProduct information
IVD Rubella IgM Control used in CLIA for checking reliability of assay run
Product use
The LIAISON® Control Rubella IgM controls (310731) are to be used in LIAISON® chemiluminescent immunoassay
(CLIA) for checking reliability of assay runs. The performance characteristics of LIAISON® controls have not been
established for any other assays or instrument platforms.
Device classification
- Risk Class
- Annex II List B
- Product Category
- Chemicals
- Product Type
- IVD
Registration information
- Registration ID
- ME0000003094SFDAA00054
- Authorization ID
- MDMA-1-2019-4213
- Status
- Active
- Expire Date
- May 26, 2025
Manufacturer
- Manufacturer Name
- DiaSorin S.p.A.
Model information
- Model ID(s)
- 310731
Product accessories
[]
About this record
Access comprehensive regulatory information for LIAISON Control Rubella IgM in the Saudi Arabia medical device market through Pure Global AI's free database. This Annex II List B device is registered with Saudi Arabia SFDA under registration number ME0000003094SFDAA00054 and manufactured by DiaSorin S.p.A..
This page provides complete registration details including product category (Chemicals), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.
Free DatabasePowered by Pure Global AISFDA Official DataAnnex II List B